LBX (603883.SH) Latest News & Headlines

Weekly Recap | PDD -5.35%, consensus target well above spot

Weekly Review·2 days ago, 06:29 AM

- Pinduoduo fell 5.35 % this week to close at 77.81 USD, underperforming the S & P 500 amid a broader decline in Chinese ADRs. - Thirty-eight institutions maintain a consensus buy rating with a target price of 115.28 USD, though valuation ranges and JPMorgan 's industry preferences reflect ongoing divergence. - Future performance will depend on Temu ecosystem developments, sector profit shifts, and upcoming macroeconomic retail data.

PDD+2.02%PDDL+4.14%

Policy dividends continue to be released, and the pharmaceutical retail industry welcomes new opportunities for transformation

Wallstreetcn·Feb 14 at 12:17 AM

512010-0.27%603939+0.71%

Pharmaceutical commercial stocks opened higher, with Yifeng Pharmacy hitting the daily limit, followed by DSL, Jointown, Hezong Medicine Easy-To-Buy Pharmaceutical, SYPM, and LBX. In terms of news, the Ministry of Commerce and 8 other departments issued the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Retail Industry."

Wallstreetcn·Jan 23 at 01:32 AM

300937-1.71%301017-0.08%

Ministry of Finance: In 2025, issue ultra-long-term special government bonds worth 1.3 trillion yuan to continuously support "two highs" and "two new"

Wallstreetcn·Jan 20 at 07:13 AM

603883-0.62%

Ministry of Industry and Information Technology: Promote overall supply adaptation to maximize consumer potential

Wallstreetcn·Nov 27, 2025 at 02:14 AM

603883-0.62%